Rafferty Asset Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,740
Closed -$221K 1142
2025
Q3
$221K Sell
1,740
-19
-1% -$2.26K ﹤0.01% 1056
2025
Q2
$216K Buy
+1,759
New +$201K ﹤0.01% 1039
2025
Q1
Sell
-2,302
Closed -$213K 1091
2024
Q4
$213K Sell
2,302
-18
-0.8% -$1.77K ﹤0.01% 1091
2024
Q3
$224K Sell
2,320
-164
-7% -$14.7K ﹤0.01% 1082
2024
Q2
$213K Buy
+2,484
New +$208K ﹤0.01% 1119
2020
Q1
Sell
-17,629
Closed -$972K 661
2019
Q4
$972K Buy
+17,629
New +$957K 0.02% 559
2017
Q1
Sell
-146,340
Closed -$4.8M 541
2016
Q4
$4.8M Buy
+146,340
New +$4.75M 0.22% 39

Other funds holding EHC

Rafferty Asset Management's EHC Position: Q4 2025 in Review

Rafferty Asset Management sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 1,740 shares — an estimated $221K sold.

Rafferty Asset Management first reported a position in EHC in Q4 2016 and held it in 7 quarters. The position peaked at $4.8M in Q4 2016. 594 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

  • Rafferty Asset Management reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
  • Rafferty Asset Management sold 1,740 Encompass Health shares in Q4 2025, an estimated $221K.
  • Rafferty Asset Management first reported a position in Encompass Health in Q4 2016 and held it in 7 quarters.
  • Rafferty Asset Management's Encompass Health position peaked at $4.8M in Q4 2016.
  • 594 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on Rafferty Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.